New research reveals how fluoxetine boosts immune protection and prevents sepsis-related heart and metabolic damage.

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

This Research Topic is the second volume of the Research Topic Outcome of Sepsis and Prediction of Mortality RiskSepsis is a life-threatening condition due ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

The following is a summary of “Ability to return to work and persistent symptoms six months after viral meningitis – a ...

The following is a summary of “Hospital readmission after surviving sepsis: A systematic review of readmission reasons and meta-analysis of readmission rates,” published in the February 2025 issue of ...